Although the direct contribution of the NLRP3-Caspase-1 inflammasome to MMP-9 activation remains to be demonstrated in human aortic aneurysms, targeting this pathway with MCC950 is a promising approach for preventing aortic destruction. This evidence concerns the gene NLRP3 and aortic aneurysm.